Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
19.45
-0.05 (-0.26%)
At close: Dec 20, 2024, 4:00 PM
19.32
-0.13 (-0.67%)
After-hours: Dec 20, 2024, 4:24 PM EST
Arrowhead Pharmaceuticals Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for ARWR stock have an average target of 42.7, with a low estimate of 24 and a high estimate of 80. The average target predicts an increase of 119.54% from the current stock price of 19.45.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ARWR stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
Buy | 2 | 2 | 3 | 4 | 4 | 4 |
Hold | 3 | 3 | 3 | 3 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 9 | 10 | 11 | 12 | 12 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +311.31% | Dec 20, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +208.48% | Dec 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $80 | Strong Buy | Maintains | $60 → $80 | +311.31% | Dec 3, 2024 |
Bernstein | Bernstein | Hold Maintains $27 → $24 | Hold | Maintains | $27 → $24 | +23.39% | Nov 29, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $62 → $45 | Buy | Maintains | $62 → $45 | +131.36% | Nov 27, 2024 |
Financial Forecast
Revenue This Year
153.59M
from 3.55M
Increased by 4,225.26%
Revenue Next Year
244.95M
from 153.59M
Increased by 59.48%
EPS This Year
-4.31
from -5.00
EPS Next Year
-3.79
from -4.31
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 464.8M | 423.2M | 990.4M | ||
Avg | 153.6M | 245.0M | 393.6M | ||
Low | n/a | 111.4M | 84.6M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 12,990.4% | 175.5% | 304.3% | ||
Avg | 4,225.3% | 59.5% | 60.7% | ||
Low | - | -27.4% | -65.5% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -1.85 | -1.49 | 1.86 | ||
Avg | -4.31 | -3.79 | -2.46 | ||
Low | -6.16 | -5.78 | -4.26 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.